Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02476396 · ClinicalTrials.gov registry record
Structural Stability of Carotid Plaque and Symptomatology
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 176
- Enrollment target
NCT02476396: Completed study, sponsored by University of Wisconsin, Madison.
NCT02476396 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 176 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02476396 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 176 participants
- Enrollment target
Study Summary
The purpose of the research is to understand structural plaque abnormalities that make a carotid plaque unstable and brake off (embolize) which would help to predict and treat individuals who are likely to suffer not only classic episodic major strokes but also cognitive impairment.
Primary Outcome
Ultrasound Radio frequency (RF) data will be acquired on patients, using both one-dimensional (1D) and two-dimensional (2D) wobbler and/or matrix array transducers to obtain four-dimensional (3D + time) RF data sets. The hypothesis is that plaques which have a lower gray scale median value and which during deformations of the cardiac cycles show larger stress concentrations in these regions are more vulnerable to rupture.
Interventions
- PROCEDURE Carotid Endarterectomy or Stenting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2015-11-09 |
| Est. Completion | 2024-07-14 |
What the finished NCT02476396 record still lists
NCT02476396 is an observational study that tracks outcomes without assigning an intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Carotid Endarterectomy or Stenting is the first listed.
NCT02476396 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02476396 about?
NCT02476396 is a clinical study titled "Structural Stability of Carotid Plaque and Symptomatology". The purpose of the research is to understand structural plaque abnormalities that make a carotid plaque unstable and brake off (embolize) which would help to predict and treat individuals who are likely to suffer not only classic episodic major strokes but also cognitive impairment.
What is the current status of trial NCT02476396?
This trial is currently completed. The enrollment target is 176 participants. The study started on 2015-11-09. Estimated completion is 2024-07-14.
What interventions are being tested in trial NCT02476396?
The interventions under investigation include: Carotid Endarterectomy or Stenting (PROCEDURE).
Who is sponsoring clinical trial NCT02476396?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI